Sustained remission in large-Vessel vasculitis: Do they ever burn out?
Drug-free remission is the ideal end point for any chronic disease. Although there are data on drug-free remission in rheumatoid arthritis and lupus, such data are limited for most vasculitis. Notably, there is less evidence for disease-modifying agents in large-vessel vasculitis (LVV). Thus, we exp...
Saved in:
| Main Authors: | Sakir Ahmed, Padmanabha Shenoy, Debashish Danda, Ramnath Misra |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2019-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2019;volume=14;issue=4;spage=304;epage=311;aulast=Ahmed |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current imaging techniques in large vessel vasculitis
by: T. V. Beketova, et al.
Published: (2022-03-01) -
International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results
by: T. V. Beketova, et al.
Published: (2016-10-01) -
Review of guideline for the management of large vessel vasculitis presented in 2021 by the American College of Rheumatology / Vasculitis Foundation
by: T. V. Beketova, et al.
Published: (2022-05-01) -
Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
by: Carmen Lasa-Teja, et al.
Published: (2025-01-01) -
Effectiveness and safety of TNF-α inhibitors and il-6 pathway antagonists for refractory Takayasu arteritis
by: V. E. Logina, et al.
Published: (2024-12-01)